Notification of Government Analysts at RDTL Guwahati as MDTO

## Policy Analysis Report: Amendment to Medical Devices Rules, 2017 **1. Executive Summary:** This report analyzes an amendment to the Medical Devices Rules, 2017, as published in the Gazette of India, Extraordinary, Part II, Section 3, Subsection ii, on September 2, 2021, under S.O. 3596(E). This amendment modifies the table within the original notification S.O. 3400(E) dated July 11, 2018, by substituting entry number 15 regarding Regional Drugs Testing Laboratory, Guwahati. The key finding is the updated list of personnel associated with the Regional Drugs Testing Laboratory, Guwahati, and their assigned medical devices for testing. **2. Introduction:** This report aims to provide a comprehensive overview of the amendment to the Medical Devices Rules, 2017, as detailed in notification S.O. 3596(E) published on September 2, 2021. The analysis is based solely on the information provided in the policy text. **3. Policy Overview:** * **Original Policy Being Amended:** The amendment modifies the notification S.O. 3400(E), dated July 11, 2018, which was published in Part II, section 3, subsection ii of the Gazette of India, Extraordinary. * **Core Objective(s):** The original policy, as inferred from the amendment, pertains to the regulation and testing of medical devices, with a specific focus on assigning personnel to specific testing responsibilities. The amendment maintains this overall objective. **4. Background and Rationale:** The amendment likely addresses a need to update the designated personnel and/or assigned responsibilities within the Regional Drugs Testing Laboratory, Guwahati. The substitution of entry number 15 suggests a change in staff, their designations, or the scope of medical devices they are authorized to test. This could be due to personnel changes, expansions in the lab's capabilities, or realignment of responsibilities to improve efficiency or address emerging needs in medical device testing. **5. Key Provisions / Changes:** The amendment specifically focuses on substituting entry number 15 in the table of the original notification S.O. 3400(E). * **Specific Part Changed:** The table within notification S.O. 3400(E) related to Regional Drugs Testing Laboratory, Guwahati. * **New Rule/Provision:** The amended entry assigns the following personnel and medical devices for testing: * Shri Amar Jyoti Chamuah: Disposable Hypodermic Syringes, Disposable Hypodermic Needle, * Shri Dilip Kr. Sarkar: Disposable Perfusion Sets and Intravenous * Smt. Rinku Kalita: Cannulae * Shri Arun Kumar Das: * **Difference/Effect of Change:** The change provides an updated list of individuals responsible for testing specific medical devices at the Regional Drugs Testing Laboratory, Guwahati. This likely ensures clarity and accountability regarding testing responsibilities, potentially improving the efficiency and effectiveness of medical device regulation and oversight. **6. Target Audience and Stakeholders:** The primary target audience includes: * The Regional Drugs Testing Laboratory, Guwahati, and its personnel. * Manufacturers and suppliers of Disposable Hypodermic Syringes, Disposable Hypodermic Needle, Disposable Perfusion Sets and Intravenous Cannulae. * The Ministry of Health and Family Welfare, specifically the Department of Health and Family Welfare. **7. Implementation Aspects (Inferred):** * **Responsible Agency/Bodies:** The Ministry of Health and Family Welfare, specifically the Department of Health and Family Welfare, is responsible for implementing the changes. The Regional Drugs Testing Laboratory, Guwahati, is directly impacted by the changes and will need to adhere to the updated assignments. * **Timelines/Procedures:** The order comes into force from the date of its publication in the Official Gazette (September 2, 2021). Specific procedures for implementation beyond adhering to the new personnel assignments are not detailed in the provided text. **8. Expected Outcomes / Impact of Changes:** The intended outcome of this amendment is likely to streamline and enhance the testing and regulation of specified medical devices. By clearly assigning responsibility to specific individuals, the amendment aims to: * Improve accountability in the testing process. * Facilitate efficient monitoring of the quality and safety of medical devices. * Support the overall regulatory framework for medical devices in India. **9. Conclusion:** This amendment to the Medical Devices Rules, 2017, focuses on updating personnel assignments within the Regional Drugs Testing Laboratory, Guwahati. The changes are expected to improve the efficiency and effectiveness of medical device testing and regulation. The significance of this amendment lies in its contribution to ensuring the quality and safety of medical devices available in the market.

Key Entities Referenced